BR112013010270A2 - polimorfos de febuxostato - Google Patents

polimorfos de febuxostato

Info

Publication number
BR112013010270A2
BR112013010270A2 BR112013010270A BR112013010270A BR112013010270A2 BR 112013010270 A2 BR112013010270 A2 BR 112013010270A2 BR 112013010270 A BR112013010270 A BR 112013010270A BR 112013010270 A BR112013010270 A BR 112013010270A BR 112013010270 A2 BR112013010270 A2 BR 112013010270A2
Authority
BR
Brazil
Prior art keywords
febuxostat
polymorphs
febuxostat polymorphs
Prior art date
Application number
BR112013010270A
Other languages
English (en)
Inventor
Ehud Marom
Shai Rubnov
Original Assignee
Mapi Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mapi Pharma Ltd filed Critical Mapi Pharma Ltd
Publication of BR112013010270A2 publication Critical patent/BR112013010270A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
BR112013010270A 2010-10-28 2011-03-17 polimorfos de febuxostato BR112013010270A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40746510P 2010-10-28 2010-10-28
PCT/IL2011/000258 WO2012056442A1 (en) 2010-10-28 2011-03-17 Polymorphs of febuxostat

Publications (1)

Publication Number Publication Date
BR112013010270A2 true BR112013010270A2 (pt) 2016-07-05

Family

ID=45993241

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013010270A BR112013010270A2 (pt) 2010-10-28 2011-03-17 polimorfos de febuxostato

Country Status (8)

Country Link
US (1) US20130225830A1 (pt)
EP (1) EP2632270A1 (pt)
CN (1) CN103200821A (pt)
AU (1) AU2011322099A1 (pt)
BR (1) BR112013010270A2 (pt)
CA (1) CA2814411A1 (pt)
IL (1) IL226041A0 (pt)
WO (1) WO2012056442A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2692342A1 (en) * 2012-07-30 2014-02-05 Interquim, S.A. Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets
CN103467412B (zh) * 2013-09-30 2015-05-13 杭州朱养心药业有限公司 用于痛风的药物化合物
CZ27857U1 (cs) 2014-12-12 2015-02-23 Zentiva, K.S. Formulace obsahující tuhý roztok febuxostatu
PL236614B1 (pl) * 2017-12-14 2021-02-08 Gedeon Richter Polska Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca febuksostat oraz sposób jej wytwarzania

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN182496B (pt) * 1996-02-20 1999-04-17 Reddy Research Foundation
DE69941672D1 (de) * 1998-06-19 2010-01-07 Teijin Ltd Polymorphe modifikationen der 2-(3-cyano-4-isobutylphenyl)-4-methyl-5-thiazol-carbonsäure und verfahren zu ihrer herstellung
US20100160653A1 (en) * 2006-03-21 2010-06-24 Dr. Reddy's Laboratories Ltd. Docetaxel polymorphs and processes
SG183721A1 (en) * 2007-11-27 2012-09-27 Ardea Biosciences Inc Novel compounds and compositions and methods of use
WO2009092070A1 (en) * 2008-01-17 2009-07-23 Sicor Inc. Polymorph form iii of sorafenib tosylate, sorafenib tosylate methanol solvate and sorafenib tosylate ethanol solvate, and processes for preparation thereof
PL2381786T3 (pl) * 2009-01-29 2015-06-30 Mapi Pharma Ltd Dimetylosulfotlenkowy solwat darunawiru

Also Published As

Publication number Publication date
CN103200821A (zh) 2013-07-10
WO2012056442A1 (en) 2012-05-03
CA2814411A1 (en) 2012-05-03
US20130225830A1 (en) 2013-08-29
AU2011322099A1 (en) 2013-05-02
EP2632270A1 (en) 2013-09-04
IL226041A0 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
BR112013009935C8 (pt) compostos
BR112013003753A2 (pt) compostos
BR112012028556A2 (pt) Indóis
DE102011100241A8 (de) Nitridhalbleiterbauteil
DK3225404T3 (da) Fluidpatron
CR20130111A (es) Triazina-oxidiazoles
DE10170954T8 (de) Mikrowellendruckgarer
DE112011104226A5 (de) Käfigmutter
CO6801726A2 (es) Compuestos
DE102011117046A8 (de) Doppelkupplungswindungsgetriebe
DK2649070T3 (da) Triazolpyridinforbindelser
DE112011101226A5 (de) Linearwegmesssystem
DE112011102080A5 (de) Kupplungszentralausrücker
NO2021017I1 (no) krizanlizumab
DK2539163T3 (da) Dækventil
DK2442899T3 (da) Rotorskive
DE102011002623A8 (de) Ventilsteuerzeitversteller
DE112011102711A5 (de) Hydrostataktor
DK2448659T3 (da) Rotorskive
DK2447426T3 (da) Vaske-WC
DE102010019119B8 (de) Cuttermesser
DE112010005518A5 (de) Dichtungsmanchette
DE102010038420A8 (de) Reinigungungsvorrichtung
DK2596072T3 (da) Bor-forbindelses-suspension
DK2521486T3 (da) Palpometer

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]